BALI vs SCHD
iShares US Large Cap Premium Income Active ETF vs Schwab US Dividend Equity ETF
Which is better, BALI or SCHD?
Large Cap Growth against Large Cap Value.
SCHD has a lower expense ratio. BALI led over 3Y and the full window, SCHD over 1Y. BALI is less concentrated, with 34.9% of the fund in its ten largest positions against 41.8%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | BALI | SCHD |
|---|---|---|
| Expense Ratio | 0.35% | 0.06%Best |
| AUM | $1.4B | $112.1B |
| Dividend Yield | 7.65% | 3.00% |
| Holdings | 206 | 103 |
| YTD Return | +10.40% | +24.59%Best |
| 1Y Return | +15.37% | +28.14%Best |
| 3Y Return (annualized) | +19.64%Best | +15.58% |
| 5Y Return (annualized) | - | +9.90% |
| Volatility (annualized) | 10.4%Best | 13.3% |
| Max Drawdown | -16.6% | -16.1%Best |
| $10,000 over 3 years | $17,125Best | $16,016 |
| Top 10 Weight | 34.9%Best | 41.8% |
| Fund Family | BlackRock, Inc. (US) | Charles Schwab Asset Management |
| Category | Equity | Equity |
| Style | Large Cap Growth | Large Cap Value |
| Inception | Sep 26, 2023 | Oct 20, 2011 |
Volatility and max drawdown, and the $10,000 over 3 years row, are measured over the window both funds cover: Sep 28, 2023 to Sep 10, 2026 (3 years).
BALI vs SCHD growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 3 years both funds cover.
BALI vs SCHD Performance
iShares US Large Cap Premium Income Active ETF (BALI) is an ETF from BlackRock, Inc. (US) and Schwab US Dividend Equity ETF (SCHD) is an ETF from Charles Schwab Asset Management. Over the past year BALI returned +15.37% while SCHD returned +28.14%. Year to date, BALI is up 10.40% versus a gain of 24.59% for SCHD.
Over three years, BALI compounded at +19.64% per year against +15.58% for SCHD.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
SCHD has been the more volatile fund, with annualized monthly volatility of 13.3% compared with 10.4% for BALI. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -16.6% for BALI and -16.1% for SCHD. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.59. They move together some of the time, and apart the rest.
Fees and Cost Over Time
BALI charges 0.35% per year while SCHD charges 0.06%. On a $10,000 position that is $35 vs $6 annually, a gap of $29 per year that compounds over a long holding period. On income, BALI currently yields 7.65% against 3.00% for SCHD.
Holdings Overlap
11.3% of BALI's money is in holdings SCHD also owns. 49.7% of SCHD's money is in holdings BALI also owns.
The two portfolios partly overlap.
The two holdings books were reported 62 days apart, BALI as of Jun 30, 2026 and SCHD as of Aug 31, 2026, so some of the difference between them is the time between the two reports rather than the funds.
22 positions in common, counted across the 199 positions we hold weights for in BALI and 100 in SCHD, against full books of 206 and 103.
What only one of them owns
Our book lists 77 positions for SCHD that do not appear in our book for BALI (50.2% of the fund), and 173 for BALI that do not appear in SCHD (87.6%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in BALI | Weight in SCHD | Difference |
|---|---|---|---|
| CVXChevron Corp. | 1.63% | 4.02% | 2.39% |
| ABTAbbott Laboratories | 0.75% | 4.69% | 3.94% |
| PGProcter & Gamble Company | 1.58% | 3.83% | 2.25% |
| AMGNAmgen Inc. | 0.45% | 4.70% | 4.25% |
| KOCoca Cola Co. | 0.90% | 4.17% | 3.27% |
| UNHUnitedhealth Group Inc. | 0.87% | 3.82% | 2.95% |
| VZVerizon Communications, Inc. | 0.59% | 3.97% | 3.38% |
| TXNTexas Instruments, Inc | 0.54% | 3.13% | 2.59% |
| LMTLockheed Martin Corp | 0.84% | 2.78% | 1.94% |
| BXBlackstone Group Inc/the Common Stock | 0.21% | 2.59% | 2.38% |
49.7% of SCHD is already inside BALI.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, BALI or SCHD?
BALI has an expense ratio of 0.35% while SCHD charges 0.06%. SCHD is the cheaper option, by $29 a year on a $10,000 investment.
Which performed better, BALI or SCHD?
Over the past year BALI returned +15.37% vs +28.14% for SCHD, so SCHD leads on 1-year performance. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, BALI or SCHD?
SCHD has been the more volatile fund at 13.3% annualized versus 10.4% for BALI. Worst drawdown: BALI -16.6% vs SCHD -16.1%.
Should I hold both BALI and SCHD?
BALI and SCHD have a monthly-return correlation of 0.59, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between BALI and SCHD?
49.7% of SCHD's money is in holdings BALI also owns. 49.7% of SCHD's is in holdings BALI also owns. They hold 22 positions in common, counted across the 199 positions we hold weights for in BALI and 100 in SCHD.
Which pays a higher dividend, BALI or SCHD?
BALI yields 7.65% while SCHD yields 3.00%, so BALI currently pays the higher dividend yield.
Is SCHD better than BALI?
SCHD has a lower expense ratio. BALI led over 3Y and the full window, SCHD over 1Y. BALI is less concentrated, with 34.9% of the fund in its ten largest positions against 41.8%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.